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Abstract
Background: Hoodia gordonii products are widely commercialized for anti-obesity purposes; however, minimal
research is available on the other health properties demonstrated by this popular herbal plant.
Methods: H. gordonii crude extracts (ethanol and ethyl acetate) were assayed for in vitro anti-HIV-1 protease (PR),
reverse transcriptase (RT) and integrase activity. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) and reducing power assays
were used for the antioxidant analysis. In addition, qualitative and quantitative phytochemical analyses of the
extracts were determined using standard methods.
Results: H. gordonii extract demonstrated good inhibition against HIV RT with IC50 values of 73.55 ± 0.04 and
69.81 ± 9.45 μg/mL for ethanol and ethyl acetate extracts, respectively. Both extracts also demonstrated inhibitory
activity against HIV PR with IC50 values of 97.29 ± 0.01 and 63.76 ± 9.01 μg/mL for ethanol and ethyl acetate extracts.
In addition, H. gordonii also showed good antioxidant activity with IC50 values of 124.6 ± 11.3 and 126.2 ± 3.15 μg/mL
obtained for ethanol and ethyl acetate extracts, respectively. The reducing power of H. gordonii extracts increased as
the concentration increased which confirmed the presence of antioxidants (reductants) in the extracts. Phytochemical
screening of H. gordonii revealed the presence of phenolics, alkaloids, terpenes, steroids, cardiac glycosides and tannins
in the ethanolic extract, while the ethyl acetate extract only showed the presence of phenolics, cardiac glycosides and
steroids. The total phenolic content was 420 ± 0.17 and 319.9 ± 0.2 mg GAE/g for the ethanol and ethyl acetate
extracts, respectively. The ethanol extract, which revealed the presence of tannins, had a tannin content of 330 ± 0.
2 mg TAE/g extract.
Conclusion: This data suggests that H. gordonii has good in vitro inhibition against selected HIV-1 enzymes as well as
antioxidant properties, suggesting new potential uses for this commercial plant.
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Background
Hoodia is a genus of succulent plants belonging to the
family Apocynaceae. It is widely used now and tradition-
ally by the San Bushmen of Southern Africa, who believe
that Hoodia is their food, water and medicine [1, 2].
Hoodia species are indigenous to the Kalahari Desert of
Southern Africa, including Namibia, South Africa, Angola
and Botswana. One of the popular Hoodia species used is
Hoodia gordonii, a desert plant traditionally used by the
San people as an appetite suppressant, thirst quencher
and to treat severe abdominal cramps, haemorrhoids,
tuberculosis, indigestion, minor infections, hypertension
and diabetes [2]. H. gordonii has been known by the
indigenous populations of Southern Africa for a long time.
For centuries this plant has been used to stave off
hunger during long and tiring hunting trips or when
food supplies were low [2]. Despite its popular use
and commercialization, the bioactivity of H. gordonii
has not been extensively studied.* Correspondence: pkapewangolo@unam.na1Department of Chemistry and Biochemistry, Faculty of Science, University of
Namibia, P/Bag 13301, Windhoek, Namibia
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A number of plants from the Apocynaceae family are
considered to be potential sources of antioxidants which
have been attributed to the high phenolic content in the
phytochemical profile of some of these plants [3–5].
Antioxidants may be defined as free radical scavengers
which protect living organisms from damage caused by
the accumulation of free radicals. Free radicals have been
implicated in various pathological conditions such as
ischemia, anaemia, asthma, arthritis, inflammation,
neurodegeneration, as well as speeding up the ageing
process and perhaps even causing certain dementias
[6–10]. Free radicals are produced by physiological
and biochemical processes, or induced by environ-
mental factors such as pollution and are capable of
reacting with membrane lipids, nucleic acids, proteins
and enzymes, and other small molecules which result
in cellular damage [11].
Oxidative stress has also been implicated in the patho-
genesis of HIV/AIDS since the virus replicates in a highly
oxidized environment [12]. There is ongoing search for
better or alternative treatment that could also serve as ad-
juvant therapy to existing anti-HIV medicines. In addition
to various severe side effects, antiretroviral (ARV) drugs
reportedly increase oxidative stress [13]; hence the need
for antioxidants as adjuvant therapy for HIV therapy. In
2015, Tabe and colleagues administered Hibiscus sabdar-
iffa (Linnaeus) juice to HIV/AIDS patients on ARV ther-
apy and reported an increase in white blood cells
compared to the control group. H. sabdariffa is a plant
with high antioxidant capacity and is consumed as a leafy
vegetable and herbal tea in many countries [14, 15]. This
study investigated the antioxidant and anti-HIV potential
of H. gordonii, a popular plant which has been commer-
cialized as a diet suppressant to aid with weight loss [2].
This data suggests potentially new applications for this
plant in the future.
Methods
Collection and preparation of plant materials
Dried plant material identified as H. gordonii was kindly
donated by Farm Vredelus in July 2014. Farm Vredelus
is a commercial medicinal plant farm based in Mariental,
Namibia. A mechanical blender was used to grind the plant
material. Plant identification was done by Silke Rugheimer
at the National Herbarium of Namibia. Voucher number
M1 [H. gordonii (Masson) Sweet ex Decne].
Extraction
Plant material (108.3 g) was macerated at room
temperature in 1 L of ethanol for 48 h. The filtrate was
then concentrated under reduced pressure using a rotary
evaporator and half of the residue obtained was further
extracted in ethyl acetate to exclude highly polar tannins
which are regarded as non-specific enzyme inhibitors
[16]. The extracts obtained were dried in a fume hood
and stored at room temperature until further use.
Phytochemical analysis
Qualitative phytochemical analysis was conducted using
standard procedures previously described [17, 18]. The
metabolites screened for were flavonoids, phenolics,
alkaloids, terpenes, steroids, cardiac glycosides, tannins
and quinones. The quantitative phytochemical analysis
of H. gordonii extracts was also carried out to determine
the total phenol and tannin contents, which are
amongst the most popular natural antioxidants re-
ported in plants [19, 20].
Test for flavonoids
Dilute ammonia solution (5 mL) was added to a portion
of the crude extract followed by addition of concentrated
H2SO4. A yellow coloration observed in each extract
indicated the presence of flavonoids.
Test for phenolics
A few drops of 5 % ferric chloride were added to extracts
dissolved in distilled water. A dark green colour indicated
the presence of phenolic compounds.
Test for alkaloids
Extracts were mixed with 2 mL of Wagner’s reagent and a
reddish brown coloured precipitate indicated the presence
of alkaloids.
Test for terpenes
The extract (5 mL) was first mixed with 2 mL of chloro-
form and 3 mL of concentrated H2SO4 was slowly added
to form a layer. A reddish brown coloration of the inter-
face indicated the presence of terpenes.
Test for steroids
0.5 mL of crude extract was mixed with 2 mL of acetic
anhydride. This was followed by the subsequent addition
of 2 mL H2SO4. A colour change from violet to blue or
green in samples indicates the presence of steroids.
Test for cardiac glycosides
Exactly 5 mL of extract was treated with 2 mL of glacial
acetic acid containing one drop of ferric chloride solution.
The mixture was layered with 1 mL of concentrated
H2SO4. A brown ring at the interface is an indication of
the presence of the cardiac glycoside constituent.
Test for tannins
Each extract (1 mL) was mixed with 1 mL of 0.008 M
Potassium ferricyanide. 0.02 M Ferric chloride in 0.1 M
HCl (1 mL) was added and observed for blue-black
coloration.
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Test for quinones
Dilute NaOH was added 1 mL of crude extract. The
development of a blue green or red coloration indicates
the presence of quinones.
Total phenolic content
The total phenolic content (TPC) of H. gordonii extracts
was carried out following a method previously described
[21], with modification. Extracts (0.5 g) macerated with
10 mL of 80 % ethanol were filtered and 2.5 mL of the
filtrate was subsequently added to 0.25 mL of 2 M
Folin–Ciocalteu reagent. The mixture was allowed to
stand for 30 min and then 2 mL of 20 % sodium carbon-
ate was added. The absorbance was measured at 650 nm
using a SpectraMax M2 plate reader. A standard calibra-
tion curve (R2 = 0.944) was constructed using various
concentrations of gallic acid (0.63, 1.25, 2.5, 5 and
10 mg/mL). TPC was expressed as milligrams (mg) of
gallic acid equivalents per gram (g) of extract (mg GAE/
g extract).
Total tannin content
The total tannin content (TTC) was conducted following
a procedure previously described [22], with modification.
Briefly, 100 mg of the sample was macerated with 5 mL
of distilled water and filtered. The filtrate (1 mL) was trans-
ferred into test tubes and mixed with 2 mL of concentrated
picric acid. Absorbance was measured at 530 nm using a
SpectraMax M2 plate reader. TTC was determined from
extrapolation of a standard calibration curve (R2 = 0.966)
prepared using various concentrations of tannic acid (0.63,
1.25, 2.5, 5 and 10 mg/mL). TTC was expressed as mg tan-
nic acid equivalents per g of extract (mg TAE/g extract).
In vitro anti-HIV assays
HIV-1 reverse transcriptase colorimetric assay
The effect of H. gordonii crude extracts on HIV-1 reverse
transcriptase (RT) was tested using an RT colorimetric
ELISA kit from Roche Diagnostics (Mannheim, Germany).
The assay was performed according to the manufacturer’s
instructions. Extracts were tested at six different concen-
trations (50, 100, 200, 400, 800 and 1000 μg/mL). The
enzyme was incubated for 1 h with extract at 37 °C. Sub-
sequent 1 h incubations included addition of an antibody
conjugated to peroxidase that binds to the digoxigenin-la-
beled DNA. In the final step, the ABTS substrate so-
lution was cleaved by the peroxidase enzyme, producing a
coloured reaction product. Doxorubicin, a known
HIV-1 RT inhibitor was used as a positive control.
The absorbance of the samples was read at 405 nm
using a SpectraMax M2 plate reader.
HIV-1 integrase assay
The Xpress HIV-1 Integrase Assay Kit (Express Biotech
International, USA) was used to measure the inhibitory
effects of H. gordonii extracts (0.1, 0.2 and 0.4 mg/mL)
on HIV-1 integrase activity. Streptavidin coated 96-well
plates were coated with a double-stranded HIV-1 LTR
U5 donor substrate oligonucleotide containing an end-
labelled biotin. Full-length recombinant HIV-1 integrase
protein was then loaded onto the oligo substrate. H.
gordonii extracts or sodium azide (standard control) was
added to the reaction plates together with a double-
stranded target substrate (TS) oligo containing 3′-end
modifications. The horseradish peroxidase (HRP)-labelled
antibody was directed against the TS 3′-end modification
and the absorbance due to the HRP antibody– tetra-
methylbenzidine peroxidase substrate reaction was mea-
sured at 450 nm using a SpectraMax M2 plate reader.
HIV-1 protease fluorogenic assay
A SensoLyte 490 HIV-1 Protease (PR) kit from AnaSpec
(San Jose, CA, USA), was used to assay H. gordonii
extracts against HIV-1 PR. Due to the limited number of
reactions of the kit, samples were tested at five concen-
trations, namely; 25, 50, 100, 200 and 400 μg/mL. Acetyl
pepstatin (AP) was used as a known standard for HIV-1
PR inhibition. Briefly, test samples were incubated at
room temperature with HIV-1 PR enzyme and substrate
for 45 min. Stop solution (50 μl) was added to each
reaction then the fluorescence intensity was measured at
Excitation/Emission = 340/490 nm using a SpectraMax
M2 plate reader.
Antioxidant activity
2, 2-Diphenyl-1-picryl-hydrazyl radical scavenging assay
2, 2-Diphenyl-1-picryl-hydrazyl (DPPH: Sigma-Aldrich,
Germany) is a stable free radical with a purple colour
and upon scavenging, these free radicals turn to yellow.
The free radical scavenging activity of the extract was
evaluated using a modified method previously described
[16]. Various concentrations of H. gordonii extracts were
mixed with 90 μM DPPH. Since DPPH is light sensitive,
incubation was done in the dark at room temperature
for 30 min. The absorbance of the resulting solution was
measured using a plate reader at 520 nm. Vitamin C
(ascorbic acid) was used as a positive control.
Reducing power assay
The ability of H. gordonii extracts to reduce iron (III)
was determined according to the Kadri’s method [23]
with some modifications. Different concentrations of
extracts were mixed with 2.5 mL of phosphate buffer
(1 M, pH 6.6) and 2.5 mL of 1 % potassium ferricyanide.
The mixture was incubated at 40 °C for 20 min. After in-
cubation, 2.5 mL of 10 % trichloroacetic acid was added
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and centrifuged for 10 min at 3000 rpm. To 2.5 mL of
this reaction mixture (upper layer), 0.5 mL of ferric
chloride and 2.5 mL of water was added. Ascorbic acid
was used as a reference standard. The absorbance was
measured at 700 nm spectrophotometrically.
Data analysis
The data is presented as mean plus or minus standard
error of the mean (M ± SEM). The 50 % inhibitory
concentrations (IC50 values) for enzymes and DPPH
assays were computed using Graphpad Prism 5 software
(Graphpad Software Inc. California, USA).
Results
Qualitative and quantitative phytochemical analysis of
H. gordonii extracts
Phytochemical results revealed the presence of a number
of phytochemicals including phenolic components, alka-
loids, terpenes, steroids and cardiac glycosides as shown
in Table 1. It was noted that quinones and flavonoids
were absent from H. gordonii extracts.
Total phenolic and tannin contents
The amount of total phenolic content of the extracts
was found to be 420 ± 0.17 and 319.9 ± 0.2 mg GAE/g
for ethanol and ethyl acetate extracts, respectively. Due
to the absence of tannins in the ethyl acetate extract, as
revealed by the phytochemical screening, the total
tannin content was only determined for the ethanol ex-
tract of H. gordonii and the amount obtained was 330 ±
0.2 mg TAE/g extract. These results indicate that H.
gordonii could be a rich source of tannins and phenolic
compounds.
In vitro anti-HIV potential of H. gordonii
Both H. gordonii ethanol and ethyl acetate extracts
exhibited good inhibition in a dose-dependent manner
(Fig. 1) against HIV-1 Reverse transcriptase (RT) with
IC50 values of 73.55 ± 0.04 and 69.81 ± 9.45 μg/mL, re-
spectively (Table 2). Doxorubicin, a known RT inhibitor
[16], was used as a positive control and inhibited HIV
RT by 68 % at 25 μg/mL (IC50 < 25 μg/mL). Both
extracts also demonstrated inhibitory activity against
HIV protease (PR) with IC50 values of 97.29 ± 0.01 and
63.76 ± 9.01 μg/mL for ethanol and ethyl acetate extracts,
respectively. Acetyl pepstatin was used as a known PR
inhibitor and inhibited HIV PR by as much as 82 % at
50 μg/mL (IC50 < 50 μg/mL). Both ethanol and ethyl acet-
ate extracts had weak inhibition against HIV-1 integrase
(IN) with <50 % inhibition at the highest concentration
tested of 400 μg/mL. Sodium azide was used as a positive
control compound for IN inhibition.
DPPH (2, 2-Diphenyl-1-picryl-hydrazyl) assay
DPPH radical scavenging is one of the most widely used
methods for assaying the antioxidant activity of com-
pounds and plant extracts. The DPPH method is easy,
rapid and sensitive; the DPPH free radical is stable at
room temperature and accepts an electron or hydrogen
to become a stable diamagnetic molecule [24].
The investigated H. gordonii extracts (ethanol and
ethyl acetate) exhibited good antioxidant properties in a
concentration dependent manner (Fig. 2). The IC50
values of the ethanol and ethyl acetate extracts were
124.6 ± 11.3 and 126.2 ± 3.15 μg/mL, respectively. DPPH
scavenging activity of the ethanol extract was slightly
higher than that of ethyl acetate extract. Ascorbic acid
was used as a standard antioxidant control (IC50 <
50 μg/mL) because of its ability to scavenge free radicals.
Reducing power assay
Determination of the ferric reducing power is a simple
direct test of antioxidant capacity. As illustrated in Fig. 3,
the conversion of Fe3+ to Fe2+ in the presence of H.
gordonii extracts could be measured as their reductive
ability. The presence of reductants such as antioxidants
in H. gordonii extracts caused the reduction of the
Fe3+/ferricyanide complex to a ferrous form. The results
(Fig. 3a) showed a concentration-dependent significant
increase (P < 0.05) in the reductive ability of H. gordonii
ethanol and ethyl acetate extracts. The results were
compared to ascorbic acid, a standard control (Fig. 3b).
Discussion
A number of glycosides have been isolated from H.
gordonii [2] and amongst these glycosides is the popular
P57 glycoside attributed to the appetite suppressant
properties of H. gordonii. The attention on H. gordonii
species was elicited by the discovery of hunger suppress-
ing glycosides. Despite its popular use, minimal reports
are available on biological studies conducted on H.
gordonii. However, the safety profile of H. gordonii
Table 1 Phytochemical analysis of H. gordonii using ethanol








Cardiac glycosides + +
Tannins + –
Quinones – –
(+): Indicates the presence of chemical constituents; (−): Indicates the absence
of chemical constituents
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extracts has already been determined in a number of in
vivo studies [25].
The only antioxidant study conducted on H. gordonii
was on glycosides isolated from the plant which did not
demonstrate antioxidant property [2]. The presence of
other phytochemicals in the crude extracts such as
phenolics, alkaloids, tannins and terpenes could be
attributed to the antioxidant potential observed in this
study. The H. gordonii ethanol extract exhibited the
highest reducing activity and these results were in agree-
ment with the high DPPH scavenging activity observed
in ethanol extracts. The total phenolic content of the
ethanol extract was relatively high compared to that of
the ethyl acetate extract and the presence of tannins in
the ethanol extract but not in ethyl acetate extract could
all be responsible for the high antioxidant potential
observed in the ethanol extract. Phenolic compounds
and tannins are widely reported as natural antioxidants
[19, 20] and the present study revealed that H. gordonii
could be a potential source of useful natural antioxidants.
H. gordonii is among the most popular anti-obesity
products on the market [26]. Obesity is a chronic disease
and amongst other morbidities, it is associated with an in-
crease in oxidative stress [27]. The role of oxidative stress
in the pathogenesis of various ailments, such as psychi-
atric, inflammatory and infectious diseases has been well
documented [6, 9, 12, 28]. The antioxidant activity
observed in the present study could contribute to the
scavenging of accumulated free radicals in mostly obese
individuals that consume H. gordonii products.
In addition to being associated with obesity, oxidative
stress has also been linked to the progression of HIV
[29] which is supported by a study that reported the
promotion of HIV replication by oxidizing agents as com-
pared to antioxidants [30]. Before the present study, there
was no literature reporting on the in vitro anti-HIV-1
properties of H. gordonii. The extracts demonstrated good
inhibition against HIV-1 reverse transcriptase and prote-
ase which are two of the three HIV enzymes that play a
major role in the replication of the virus in host cells.
Current HIV therapy targets various steps of the HIV life
cycle, which includes HIV enzymes [31]. However, this
antiretroviral therapy is often limited by adverse side
effects leading to patients discontinuing treatment and in
the process contributing to the development of HIV
drug resistant strains [31]. The search for better HIV
therapy is ongoing and the in vitro anti-HIV data
from the present study is a valuable contribution
towards this search. H. gordonii is already regarded as
a complementary and alternative medicine for the
treatment of obesity [26]. Further in vivo validation of
this research could support the use of this commer-
cial product as a supplement for HIV therapy as well
as a natural antioxidant.
Fig. 1 In vitro anti-HIV RT activity of H. gordonii ethanol (EEV1) and ethyl acetate extract (EAV2). Doxorubicin was used as a positive control. IC50
values were 73.55 ± 0.04 and 69.81 ± 9.45 μg/mL for ethanol and ethyl acetate extract, respectively
Table 2 IC50 ± S.D values of crude H. gordonii ethyl acetate and
ethanolic extracts against HIV-1 RT, PR and IN activity
Sample HIV RT (μg/mL) HIV PR (μg/mL) HIV IN (μg/mL)
Ethanol extract 73.55 ± 0.04 97.29 ± 0.01 >400
Ethyl acetate extract 69.81 ± 9.45 63.76 ± 9.01 >400
Doxorubicina <25 – –
Acetyl pepstatinb – <50 –
Sodium azidec – – <50
aA known HIV reverse transcriptase inhibitor
bA known HIV protease inhibitor
cA known HIV integrase inhibitor
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Conclusion
The in vitro anti-HIV and antioxidant data obtained in
this study suggests new potential uses of H. gordonii,
which is currently commercialized and mainly used as
an anti-obesity supplement. The chemistry of H. gordonii
has been reported as well as the isolation and
characterization of the glycosidic compounds. However,
based on the results of this work, future investigations
will also research the isolation and characterization of H.
gordonii compounds which are responsible for the above
mentioned in vitro anti-HIV-1 and antioxidant activity.
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